Clinical trial
Voriconazole With or Without Interferon Gamma in Treating Patients With…
NCT00059878 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00059878 |
|---|---|
| Title | Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections |
| Official title | A Prospective, Randomized, Double-Blind, Multicenter Pilot Study Of The Safety And Efficacy Of Interferon Gamma- 1b (IFN-y 1b) Plus Voriconazole Versus Placebo Plus Voriconazole In The Treatment Of Invasive Aspergillosis And Other Filamentous Fungal Infections |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infection, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon gamma, voriconazole |
| Start date | Aug 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | May 7, 2003 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: